Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis
References (40)
- et al.
Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia
Hum Pathol
(1992) Stereotactic breast biopsy: a surgical series
J Am Coll Surg
(1997)- et al.
Accuracy of stereotactic core-needle breast biopsy in atypical ductal hyperplasia
Am J Surg
(1998) - et al.
Mild duct atypia after large-core needle biopsy of the breast: is surgical excision always necessary?
Surgery
(2000) - et al.
Is surgical excision necessary for atypical ductal hyperplasia of the breast diagnosed by Mammotome?
Am J Surg
(2000) The woman at high risk for breast cancer: importance of hyperplasia
Surg Clin North Am
(1996)- et al.
Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia
Hum Pathol
(1992) - et al.
Nonpalpable breast lesions: stereotactic automated large-core biopsies
Radiology
(1991) - et al.
Nonpalpable breast lesions: correlation of stereotaxic large core needle biopsy and surgical biopsy results
Radiology
(1993) - et al.
Percutaneous large core breast biopsy: a multi-institutional study
Radiology
(1994)
Evaluation of nonpalpable solid breast masses with stereotaxic large-needle core biopsy using a dedicated unit
AJR
Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques
AJR
Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia
Radiology
Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy
AJR
Diagnostic accuracy of stereotactic core biopsy in a mammographic breast cancer screening programme
Histopathology
Surgical biopsy findings in patients with atypical hyperplasia diagnosed by stereotaxic core needle biopsy
Ann Surg Oncol
Nondiagnostic stereotaxic core breast biopsy: results of rebiopsy
Radiology
Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in-situ lesions: improved accuracy with directional, vacuum-assisted biopsy
Radiology
Appropriate management of atypical ductal hyperplasia diagnosed by stereotactic core needle breast biopsy
Ann Surg Oncol
Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy
Ann Surg
Cited by (42)
Underestimation of cancer in case of diagnosis of atypical ductal hyperplasia (ADH) by vacuum assisted core needle biopsy
2012, Reports of Practical Oncology and RadiotherapyCitation Excerpt :Mammotome biopsy of mammographically suspicious nonpalpable breast changes is associated with less morbidity and shorter hospital stay, lower cost compared with open surgical biopsy, which used to be a standard practice in the past. The frequency of detection of ADH by core needle biopsy is, according to different authors, from 2 to 11%.13,14 In our study, ADH was diagnosed in 134 patients, representing 3.1% of the diagnoses made on the basis of Mammotome® biopsy.
Screen-detected breast lesions with an indeterminate (B3) core needle biopsy should be excised
2008, European Journal of Surgical OncologyCitation Excerpt :If a lesion of concern is noted on the mammogram, patients are recalled for assessment that may include a clinical examination, further mammograms with special views, ultrasound (US), and collection of tissue for pathological examination by core biopsy (CB), fine needle aspiration cytology (FNAC) or both. A CB of the breast lesion usually provides a definitive diagnosis, but can at times be indeterminate.2 There are a number of histopathological changes that, if present, would result in the CB being reported as indeterminate (lesions that are “benign but of uncertain malignant potential” – coded “B3” in the NHSBSP).3
Progress Toward Non-operative Management of Atypical Ductal Hyperplasia
2024, Current Breast Cancer ReportsAtypical Ductal Hyperplasia of the Breast on Core Needle Biopsy: Risk of Malignant Upgrade on Surgical Excision
2022, Journal of Breast Cancer